Dopamine D₅ Receptor Expression is Unchanged in Peripheral Blood Lymphocytes in Essential Hypertension

References

• Clark B. J. Postjunctional dopamine receptor stimulants. Peripheral Dopamine Pathophysiology, F Amenta. CRC Press, Boca Raton 1990; 253–262
   Google Scholar
• Clark B. J. Prejunctional dopamine receptor stimulants. Peripheral Dopamine Pathophysiology, F. Amenta. CRC Press, Boca Raton 1990; 267–306
   Google Scholar
• Amenta F., Gallo P., Rossodivita A., Ricci A. Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart. Naunyn-Schmied. Arch. Pharmacol. 1993; 347: 147–154
   PubMed Web of Science ®Google Scholar
• Kuchel O. Dopamine and hypertension. Curr. Opin. Cardiol. 1990; 5: 594–600
   Web of Science ®Google Scholar
• Kuchel O. G., Kuchel G. A. Peripheral dopamine in patho-physiology of hypertension. Interaction with aging and lifestyle. Hypertension 1991; 18: 709–721
   PubMed Web of Science ®Google Scholar
• Clark B. A., Rosa R. M., Epstein F. H., Young J. B., Landsberg L. Altered dopaminergic responses in hypertension. Am. J. Hypertens. 1990; 3: 1074–1076
   Google Scholar
• Van Loon G. R., Sole M. J. Plasma dopamine: regulation and significance. Metabolism 1980; 29(Suppl 1)1119–1123
   PubMed Web of Science ®Google Scholar
• Snider S. R., Kuchel O. Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension. Endocr. Rev. 1983; 4: 291–309
   PubMed Web of Science ®Google Scholar
• Goldstein D. S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983; 5: 86–99
   PubMed Web of Science ®Google Scholar
• Miura Y., Takahashi M., Sano N., Ohzeki T., Meguro Y., Sugawara T., Noshiro T., Watanabe H., Shimizu K., Abe K., Yoshinaga K. Plasma free dopamine in human hypertension. Clin. Exper. Hypertens. 1989; A11(suppl 1)227–236
   Google Scholar
• Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P., Fonstelien E. Decreased peripheral dopaminergic activity in essential hypertension?. Scand. J. Clin. Lab. Invest. 1983; 43: 15–20
   PubMed Web of Science ®Google Scholar
• Le Fur G., Phan T., Uzan A. Identification of stereospecific [3H]-spiroperidol binding sites in mammalian lymphocytes. Life Sci. 1980; 26: 1139–1148
   PubMed Web of Science ®Google Scholar
• Fleminger S., Jenner P., Marsden D. Are dopamine receptors present on human lymphocytes?. J. Pharm. Pharmacol. 1982; 34: 658–663
   PubMed Web of Science ®Google Scholar
• Takahashi N., Nagai Y., Ueno S., Saeki Y., Yanagihara T. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudo genes. FEBS Lett. 1992; 314: 23–25
   PubMed Web of Science ®Google Scholar
• Arnold G., Bondy B., Bandmann O., Gasser T., Schwarz J., Trenkwalder C., Wagner M., Poewe W., Oertel W. H. 3H-Spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes. J. Neural. Transm. 1993; 5: 107–116
   Web of Science ®Google Scholar
• Ricci A., Amenta F. Dopamine D5 receptors in human peripheral blood lymphocytes: A radioligand binding study. J. Neuroimmunol. 1994; 53: 1–7
   PubMed Web of Science ®Google Scholar
• The Fifth Report of the Joint National Committee Guidelines on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch. Int. Med. 1993; 153: 154–183
   PubMed Web of Science ®Google Scholar
• Weicker H., Faraudi M., Hagele H., Pluto R. Electrochemical detection of catecholamines in urine and plasma after separation with high pressure liquid chromatography. Clin. Chem. Acta 1984; 141: 17–25
   PubMed Web of Science ®Google Scholar
• Cheng Y. C., Prussoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which cause inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3103
   PubMed Web of Science ®Google Scholar
• Meurs H., Van Den Bogaard W., Kauffman H. F., Bruymzeel P. L.B. Characterization of (-)-[3H]-dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes. Eur. J. Pharmacol. 1982; 85: 185–194
   PubMed Web of Science ®Google Scholar
• Wiik P., Opstad P. K., Boyum A. Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites. Reg. Peptides 1985; 12: 145–153
   PubMed Web of Science ®Google Scholar
• Calvo J. R., Molinero P., Jimenez J., Goberna R., Guerrero J. M. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells. Peptides 1986; 7: 177–184
   PubMed Web of Science ®Google Scholar
• Stanisz A. N., Scicchitano R., Dazin P., Bienenstock J., Payan D. G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 1986; 139: 749–756
   Web of Science ®Google Scholar
• Scicchitano R., Dazin P., Bienenstock J., Payan D. G., Stanisz A. N. Distribution of somatostatin receptors on murine spleen and Peyer's patch T lymphocytes. Brain Behavior. Immun. 1987; 1: 173–178
   PubMedGoogle Scholar
• Santambrogio L., Lipartiti M., Bruni A., Dal Toso R. Dopamine receptors on human T- and B- lymphocytes. J. Neuroimmunol. 1993; 45: 113–120
   PubMed Web of Science ®Google Scholar
• Felten S. Y., Olschowka J. Noradrenergic sympathetic innervation of the spleen: II Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 1987; 18: 37–48
   PubMed Web of Science ®Google Scholar
• Zentel H. J., Albrecht D. N.R., Jeurissen S. H.M., Vaino O., Weihe P. Peptidergic innervation of the Bursa Fabricii: interrelation with T-lymphocyte subsets. Int. J. Neurosci. 1991; 59: 177–188
   PubMed Web of Science ®Google Scholar
• Nagy E., Berczi I., Wren G. E., Asa S. L., Kowacs K. Immunomodulation by bromocriptine. Immunopharmacol. 1983; 6: 231–235
   PubMed Web of Science ®Google Scholar
• Seeman P., Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem. Int. 1987; 10: 1–24
   PubMed Web of Science ®Google Scholar
• Amenta F. Biochemistry and autoradiography of peripheral dopamine receptors. Peripheral Dopamine Pathophysiology, F Amenta. CRC Press, Boca Raton 1990; 39–52
   Google Scholar
• Sibley D. R., Monsma F. J., Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 1992; 13: 61–69
   PubMed Web of Science ®Google Scholar
• Gingrich J. A., Caron M. G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 1993; 16: 299–321
   PubMed Web of Science ®Google Scholar
• Boon N. A., Elliot J. M., Davies C. L. Platelet α-adrenoceptors in borderline and established essential hypertension. Clin. Sci. 1983; 63: 207–208
   Google Scholar
• Motulsky H. J., O'Connor D. T., Insel P. A. Platelet α2-adrenergic receptors in treated and untreated essential hypertension. Clin. Sci. 1983; 64: 265–272
   PubMed Web of Science ®Google Scholar
• Feldman R. D., Limbird L. E., Nadeau J., Robertson D., Wood A. J.J. Leukocyte β-receptor alterations in hypertensive subjects. J. Clin. Invest. 1984; 73: 648–653
   PubMed Web of Science ®Google Scholar
• Ashida T., Tanaka T., Yokouchi M. Effect of dietary sodium on platelet α2-adrenergic receptors in essential hypertension. Hypertension 1985; 7: 972–978
   PubMed Web of Science ®Google Scholar
• Graafsma S. J., van Tits L. J., van Heijst P., Reyenga J., Lenders J. W.M., Rodrigues de Miranda J. F., Thien T. Adrenoceptors on blood cells in patients with essential hypertension before and after mental stress. J. Hypertens. 1989; 7: 519–524
   PubMed Web of Science ®Google Scholar